These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7806383)

  • 1. Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages.
    Kelleher M; Moody SF; Mirabile P; Osborn AH; Bacic A; Handman E
    Infect Immun; 1995 Jan; 63(1):43-50. PubMed ID: 7806383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotes.
    Kelleher M; Curtis JM; Sacks DL; Handman E; Bacic A
    Mol Biochem Parasitol; 1994 Aug; 66(2):187-200. PubMed ID: 7808469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes.
    Kelleher M; Bacic A; Handman E
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):6-10. PubMed ID: 1370357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies directed against Leishmania secreted acid phosphatase and lipophosphoglycan. Partial characterization of private and public epitopes.
    Ilg T; Harbecke D; Wiese M; Overath P
    Eur J Biochem; 1993 Oct; 217(2):603-15. PubMed ID: 7693464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies.
    Späth GF; Lye LF; Segawa H; Turco SJ; Beverley SM
    Infect Immun; 2004 Jun; 72(6):3622-7. PubMed ID: 15155672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania major proteophosphoglycan is expressed by amastigotes and has an immunomodulatory effect on macrophage function.
    Piani A; Ilg T; Elefanty AG; Curtis J; Handman E
    Microbes Infect; 1999 Jul; 1(8):589-99. PubMed ID: 10611735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages.
    Straus AH; Levery SB; Jasiulionis MG; Salyan ME; Steele SJ; Travassos LR; Hakomori S; Takahashi HK
    J Biol Chem; 1993 Jun; 268(18):13723-30. PubMed ID: 8514804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of beta-D-galactofuranose in Leishmania major macrophage invasion.
    Suzuki E; Tanaka AK; Toledo MS; Takahashi HK; Straus AH
    Infect Immun; 2002 Dec; 70(12):6592-6. PubMed ID: 12438330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of Leishmania major amastigote lipophosphoglycan.
    Moody SF; Handman E; McConville MJ; Bacic A
    J Biol Chem; 1993 Sep; 268(25):18457-66. PubMed ID: 8360147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation.
    Späth GF; Beverley SM
    Exp Parasitol; 2001 Oct; 99(2):97-103. PubMed ID: 11748963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of Leishmania major-infected macrophages by use of lipophosphoglycan-specific monoclonal antibodies.
    Handman E
    Infect Immun; 1990 Jul; 58(7):2297-302. PubMed ID: 1694823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional aspects of the Leishmania donovani lipophosphoglycan during macrophage infection.
    Descoteaux A; Turco SJ
    Microbes Infect; 2002 Jul; 4(9):975-81. PubMed ID: 12106791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana.
    Bahr V; Stierhof YD; Ilg T; Demar M; Quinten M; Overath P
    Mol Biochem Parasitol; 1993 Mar; 58(1):107-21. PubMed ID: 8459823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody.
    Barbiéri CL; Giorgio S; Merjan AJ; Figueiredo EN
    Infect Immun; 1993 May; 61(5):2131-7. PubMed ID: 7683002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of glycoinositol phospholipids in the amastigote stage of the protozoan parasite Leishmania major.
    Schneider P; Rosat JP; Ransijn A; Ferguson MA; McConville MJ
    Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):555-64. PubMed ID: 8240257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species.
    McConville MJ; Schnur LF; Jaffe C; Schneider P
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):807-18. PubMed ID: 7575413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of macrophage response elicited by glycoinositolphospholipids and lipophosphoglycan from Leishmania (Viannia) shawi.
    Passero LF; Assis RR; da Silva TN; Nogueira PM; Macedo DH; Pessoa NL; Campos MA; Laurenti MD; Soares RP
    Parasitol Int; 2015 Aug; 64(4):32-5. PubMed ID: 25619843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Leishmania (Leishmania) tropica axenic amastigotes.
    Nasereddin A; Schweynoch C; Schonian G; Jaffe CL
    Acta Trop; 2010 Jan; 113(1):72-9. PubMed ID: 19782652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis.
    Dermine JF; Scianimanico S; Privé C; Descoteaux A; Desjardins M
    Cell Microbiol; 2000 Apr; 2(2):115-26. PubMed ID: 11207568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.